Human distribution and release of a putative new gut hormone, peptide YY
Box 6 presents recommendations from the consensus panel for hybrid therapy
GLP-1 receptor agonists like Semaglutide and Liraglutide have demonstrated effectiveness in reducing insulin resistance, normalizing menstruation, and promoting weight loss in PCOS patients
Mantovani A, Byrne CD, Targher G (2022) Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review
[ [PMID: 37897034] [161] Fathizadeh, H
Qie R, Zhang D, Liu L, et al